Editorial Note: This article is an internal production sample used exclusively for contributor outreach. All content, author bios, and associated data are strictly illustrative and fictional.
Every oncologist who treats breast cancer knows the patient who had a normal mammogram and then, months later, found a lump. These "interval cancers," diagnosed between scheduled screenings, are among the most frustrating cases in cancer care. They are often more aggressive or advanced than cancers found at routine screening, and estimates suggest 20% to 30% could have been spotted on the earlier mammogram.
A major study published in The Lancet in early 2026 suggests artificial intelligence can help reduce that number. It is the strongest evidence yet that AI can improve cancer screening in the real world, and it deserves careful interpretation.
